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Valorization 
As a scientist it is important to contribute not only to science, but also to society. This 
entails reflecting on your own work and the possible implications your work may have 
on society as a whole. The ministry of Education, culture and science uses the following 
definition: “valorization is the process of creating value from knowledge by making 
knowledge suitable and/or available for economic and/or societal use and translating 
that knowledge into products, services, processes and/or entrepreneurial activity”1. 
Examples of neuroscientific knowledge finding its way in the field of psychiatry could be 
the development of new medicines, non-pharmacological treatments, diagnostic 
procedures, and guidelines. Valorization is an essential objective of a good scientist. You 
have a responsibility towards society to inspire, share your knowledge and to bridge the 
gap between science and society. There are several ways to achieve this goal. This 
chapter is an attempt to explore potential influences of the work described in this thesis 
on society. Besides writing this chapter, I have been involved in several other activities 
related to valorization in the past four years, as highlighted in my CV and the personal 
portfolio at the end of this thesis. A range of topics are important when discussing the 
potential societal benefit(s) of science in general and the work in this thesis specifically, 
and some major points are addressed below.  
Implications for patients and their families 
A clear societal impact of the research described in this thesis is the potential 
implications for the clinical practice of people with mental disorders in general and with 
the 22q11.2 deletion syndrome (22q11DS) specifically. An important aim when 
investigating clinical populations is to reduce any suffering caused by the disorder and 
to gain insights that can be useful for potential treatment options for patients. 
Knowledge about underlying neurobiological systems related to the psychiatric 
symptoms in 22q11DS and mental disorders in general, can influence decisions by policy 
makers, insurance companies and other professionals in the future as well. 
During the data collection of this PhD project I was fortunate to meet a lot of 
different people with 22q11DS and their families. One place especially made an impact 
on me due to the dedicated care of a family for their son with 22q11DS, encouraging 
them to open a housing facility for people with intellectual disabilities. A housing 
community for people in need of extra care and support in their day-to-day life. During 
one of my home visits I met Lucas (this case is anonymized) who had been living in this 
housing facility already for a number of years. He felt happy and accepted in that 
environment. He participated in my PhD studies because he wanted to contribute to 
more awareness, knowledge and insight into 22q11DS, thereby ultimately helping other 
people suffering from the syndrome.  
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To other people with 22q11DS he wanted to say: “interact with people you can trust, 
who understand you and who care for you”. Another boy with 22q11DS and past 
psychotic episodes also lived at the facility and was eager to participate in my research, 
aiming to help increase the awareness for 22q11DS in society. To other people with 
22q11DS he wanted to say: “accept who you are, don’t demand too much from yourself. 
Listen to your disabilities and don’t care too much about the opinion of others.”  
Besides these two examples, many of the other participants and especially their 
families and peers told us that one of their primary reasons to participate in the research 
was to increase awareness for 22q11DS in society and amongst clinicians. Therefore, we 
hope that also the work described in this thesis will contribute to more awareness for 
22q11DS in society.  
Despite 22q11DS being one of the most common genetic syndromes in the world 
with a prevalence of 1 in 2000 to 4000 births2, it is still highly unknown. Patients and 
their families have to deal with a lot of misunderstanding of 22q11DS in society. This 
was one of the main frustrations and challenges the caretakers, family and patients 
shared with me during my visits in their daily life situations. The general lack of 
awareness of the syndrome sometimes decreased their ability of getting the right 
treatment, support and care they were looking for. When a syndrome and its 
characteristics are unknown, it is harder to be acknowledged, have access to sufficient 
treatment, suitable education, feasible jobs and also to generally feel accepted in 
society. More awareness and acceptance are therefore of great importance to 
improving the quality of life of the patients and their environments. “VG netwerken” 
and “Stichting Steun 22q113” have done a great job in raising more awareness in society, 
with their slogan “unknown leads to misunderstanding”. However, awareness still 
remains a huge challenge and more scientific research and evidence, like described in 
this thesis, is therefore necessary to explain why 22q11DS increases risk for several 
symptoms and why having this syndrome can severely impact your daily life.  
The work described in this thesis is part of the research conducted in the “22q11DS 
international Brain and Behavior Consortium”2 in which scientists from all over the world 
collaborate to gain more insights into mental disorders and cognitive problems related 
to the syndrome. By combining the expertise of different international scientific 
departments, it is expected to better understand why some people (with 22q11DS) do- 
and others do not - develop mental disorders. Our results are believed to add a valuable 
piece to the complex puzzle of causal factors leading to mental disorders, including 
aberrant reward and stress processing in 22q11DS (chapters 1,2,3,5 and 6), which might 
ultimately lead to new treatment methods and an improved quality of life of patients 
and their families.  
The work in this thesis could also have implications for patients without 22q11DS 
with mental disorders including psychotic disorders. To increase prevention and the 
success of treatment, it is useful to improve the understanding of underlying 
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neurobiological mechanisms in 22q11DS, a population at high genetic risk for developing 
psychotic disorders. 
We can speculate about the clinical relevance of the findings in each individual 
chapter of this thesis. Reward and reinforcement learning impairments in 22q11DS, 
described in chapters 1 and 2, could imply a decreased hedonic component of reward 
anticipation and potentially aberrant reward sensitivity. It could be speculated that 
people with 22q11DS need other (more) rewarding stimuli in order to feel motivated, 
compared to people without 22q11DS. This should be taken in to account when 
professionals (deciding about suitable treatment options) and other people in the direct 
living situation (e.g. family, school, work situations) want to create the best possible 
environment for individuals with 22q11DS to flourish. More research is necessary to 
decide what kind of rewarding and motivational incentives would most appropriate and 
important to individuals with 22q11DS. 
The results described in chapter 4 show that pre-pulse inhibition (PPI) is a valuable 
method to investigate specific endophenotypes related to information processing and 
brain functioning in 22q11DS, given the lack of invasiveness. Results of studies using this 
method could potentially be valuable in the clinical settings as well, however more 
research is currently necessary to relate the findings on information processing to 
societal impact for 22q11DS.  
Our findings of both chapters 3 and chapter 5, suggest a frontal hyperdopaminergic 
state and hypocortisolism in adults with 22q11DS, which could have (clinical) 
implications for people with 22q11DS. The results suggest that the 22q11.2 deletion 
could cause over-activation, sensitization or even exhaustion of the catecholamine and 
endocrine systems (e.g. the hypothalamic-pituitary-adrenal-gland (HPA)-axis) 
throughout the developmental trajectories in 22q11DS, which could lead to dysfunction 
of these systems later in life. We therefore propose that 22q11DS should be seen as a 
developmental syndrome that can severely disrupt these systems over time, potentially 
related to the increased risk for mental disorders in individuals with 22q11DS. A 
genetically programmed abnormal dopamine (DA) and stress system could perhaps 
precede psychopathology in 22q11DS. The sensitization of the stress system could for 
example result in different stress reactivity in 22q11DS. Minor daily life challenges (or 
unexpected events) might be experienced more stressful (traumatic), potentially 
associated to the high levels of chronic stress and anxiety in (children with) 22q11DS. 
Our results on altered cortisol functioning add valuable new evidence for the endocrine 
impairments in 22q11DS which should be taken in to account when (new) treatment 
guidelines are designed.  
Our experience sampling results in chapter 6 show that in general adults with 
22q11DS report more negative mood throughout the day, which could have implications 
for guidelines and day-to-day interaction in society. This negative mood could be related 
to the high rates (especially the negative symptoms) of psychotic disorder, anxiety and 
mood disorders reported in 22q11DS4,5. More research is necessary to indicate if a 
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relationship between abnormal stress reactivity and psychiatric symptoms is present in 
22q11DS, as it is in other populations with (a risk of) psychiatric disorders. It is 
additionally interesting to explore clinical intervention possibilities in 22q11DS. These 
interventions could either focus on the reduction of stressful events in the environment 
of people with 22q11DS, or on modifying emotional reactivity to stress, in order to 
improve resilience and coping strategies, for instance using acceptance and 
commitment therapy, or mindfulness-based stress reduction.  
Summarizing, the key points to take away from the results described in this thesis, 
related to treatment possibilities are that:  
• Individuals with 22q11DS might experience an emotional or sensory overload, 
possibly resulting in, or resulting from, an oversensitive HPA-axis, frontal 
hypodopaminergic functioning, aberrant reward sensitivity and aberrant stress 
reactivity.  
• Our results indicate: 
o a mismatch between stressful events, the emotional- and the biological response 
(HPA-axis functioning) to (minor) stressful daily activities.  
o a mismatch between rewarding stimuli and the biological response (reward-
network activation and DA release) to these rewarding events in the environment.  
• Minor daily life challenges (or unexpected events) may be experienced as more 
stressful and the general appraisal of daily life experiences could be more negative 
and/or less rewarding 
• The results in this thesis could potentially be associated to the high levels of mood 
disorders, psychotic disorder, chronic stress and anxiety in 22q11DS and should 
therefore be considered when designing treatment options.  
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